Development of a riboflavin and ultraviolet light-based device to treat whole blood.
about
Pathogen inactivation technologies for cellular blood components: an updateBabesia: an emerging infectious threat in transfusion medicineTreatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood StorageHuman Immunodeficiency Virus (HIV).Pathogen reduction of whole blood: utility and feasibility.The effectiveness of riboflavin and ultraviolet light pathogen reduction technology in eliminating Trypanosoma cruzi from leukoreduced whole blood.Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage.Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Large animal evaluation of riboflavin and ultraviolet light-treated whole blood transfusion in a diffuse, nonsurgical bleeding porcine model.Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols.Identification of potential protein quality markers in pathogen inactivated and gamma-irradiated red cell concentrates.p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment.
P2860
Q28655769-939E195A-1E4D-4198-9C3C-5C5855059F29Q34819404-6FE28DBA-4F17-4E4F-95FE-76E92BD6DECCQ35841288-AD1A2976-0026-4635-894D-6A8CF0E0C613Q37045832-17BB378E-021C-4305-AA71-2E56DD2D943AQ40056466-14A67342-194E-4D6C-8423-63E37A321C11Q40246814-C7C15430-58A4-4557-8219-A682DF6C88A7Q40267288-90C57F2A-7C14-435B-8268-310185C83EC6Q40611312-6F8808AE-9998-4D76-8BE1-B84BF06953A5Q40942917-AB6FC4AB-8307-4BEF-80DC-6FA96DBE0121Q41591514-B055136D-379B-4088-91FE-3296D5BB1933Q50215215-0CCCABCB-6603-45C6-9BF2-EE70D6BB144AQ50219068-7B293DFE-748A-4BBB-A270-AA18B28BA3ACQ54310409-F40EAAA4-C999-4CFC-B1EE-1247389CFA41
P2860
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@en
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@nl
type
label
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@en
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@nl
prefLabel
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@en
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@nl
P2093
P2860
P356
P1433
P1476
Development of a riboflavin and ultraviolet light-based device to treat whole blood.
@en
P2093
Heather L Reddy
Raymond P Goodrich
Shawn D Keil
Susanne Marschner
Suzann K Doane
P2860
P304
P356
10.1111/TRF.12047
P478
53 Suppl 1
P577
2013-01-01T00:00:00Z